tert-Butyl 7-oxo-2,6-diazaspiro[3.4]octane-2-carboxylate

Catalog No. :
ACQVRO218
CAS No. :
1234616-51-3
Molecular Formula :
C11H18N2O3
Molecular Weight :
226.28

IUPAC Name:tert-butyl 7-oxo-2,6-diazaspiro[3.4]octane-2-carboxylate

tert-Butyl 7-oxo-2,6-diazaspiro[3.4]octane-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$135.00Login to see priceIn stockIn stock
25g95%$448.00Login to see priceIn stockIn stock
100g95%$1519.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 7-oxo-2,6-diazaspiro[3.4]octane-2-carboxylate
IUPAC Nametert-butyl 7-oxo-2,6-diazaspiro[3.4]octane-2-carboxylate
MDL No.MFCD18325190
Molecular FormulaC11H18N2O3
Molecular Weight226.28
SMILESCC(C)(C)OC(=O)N1CC2(C1)CNC(=O)C2
InChI KeyIRALTYPUIGPWFA-UHFFFAOYSA-N
Synonym1234616-51-3 | tert-butyl 7-oxo-2,6-diazaspiro[3.4]octane-2-carboxylate | 7-OXO-2,6-DIAZASPIRO[3.4]OCTANE-2-CARBOXYLIC ACID TERT-BUTYL ESTER | TERT-BUTYL 6-OXO-2,7-DIAZASPIRO[3.4]OCTANE-2-CARBOXYLATE | MFCD18325190 | 2,6-Diazaspiro[3.4]octane-2-carboxylic acid, 7-o
CAS No.1234616-51-3
PubChem CID56777107

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACQVRO218 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQVRO218 route product structure diagram
    ACQVRO2181234616-51-3 In Stock
Inquiry

2. ACQVRO218 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCYMO549 route compound structure diagram
    ACCYMO5491956355-12-6 In Stock
  4. Then
  5. ACQVRO218 route product structure diagram
    ACQVRO2181234616-51-3 In Stock
Inquiry

Comments (0)